Ligand Pharmaceuticals Inc (LGND)

Net Change in Cash

$891.61M

Quarterly · Period ending: · USD

LGND logo

LGND Net Change in Cash

Latest reported$891.61M
LGND Quarterly Net Change in Cash ($500.00K → $891.61M)
High-resolution chart · PNG

LGND net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
891,608,000
-59,833,000
35,551,000
71,707,000
19,680,000
-24,318,000
8,688,000
45,480,000
-31,954,000
27,139,000
3,679,000
-8,587,000
-60,283,000
43,722,000
40,890,001
-1,164,000
-9,713,000
-4,529,000
-3,908,000
1,423,000
-10,190,000
-15,766,000
-409,144,000
341,220,000
-2,371,000
45,984,000
-154,040,000
-48,087,000
167,031,000
-12,411,000
-39,426,000
7,747,000
100,435,000
30,404,000
-12,119,000
-27,484,000
49,582,000
-8,111,000
-67,828,000
25,230,000
30,057,000
-66,135,000
3,658,000
-14,468,000
-57,528,000
5,563,000
-20,460,000
166,126,000
1,560,000
1,338,000
8,368,000
-2,652,000
886,000
-7,344,000
5,335,000
-1,839,000
-892,000
2,736,000
4,790,000
-1,190,000
-2,592,000
2,687,000
-450,000
561,000
-809,000
-11,988,000
10,872,000
1,611,000
-1,371,000
-23,833,000
16,952,000
-17,376,000
-30,366,000
-17,269,000
7,511,000
-34,310,000
-300,300,000
245,510,000
148,372,000
-31,586,000
-8,193,000
-16,948,000
17,168,000
17,008,000
-18,376,000
-41,354,000
46,290,000
4,100,000
-23,638,000
6,528,000
-13,972,000
48,754,000
11,269,000
-29,444,000
19,246,000
-1,910,000
6,896,000
-2,550,000
2,986,000
-10,845,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.